MET and non-small cell lung carcinoma: Aberration of the HGF/c-MET system is well documented in several human cancers [11], such as non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (HNSCC) cancer, as well as other carcinomas.